- Saudi Arabia
- /
- Healthcare Services
- /
- SASE:4002
Mouwasat Medical Services First Quarter 2025 Earnings: Revenues Disappoint
Mouwasat Medical Services (TADAWUL:4002) First Quarter 2025 Results
Key Financial Results
- Revenue: ر.س764.3m (up 5.8% from 1Q 2024).
- Net income: ر.س197.0m (up 15% from 1Q 2024).
- Profit margin: 26% (up from 24% in 1Q 2024). The increase in margin was driven by higher revenue.
- EPS: ر.س0.99 (up from ر.س0.86 in 1Q 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Mouwasat Medical Services Revenues Disappoint
Revenue missed analyst estimates by 3.3%. Earnings per share (EPS) was mostly in line with analyst estimates.
Looking ahead, revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Healthcare industry in Saudi Arabia.
Performance of the Saudi Healthcare industry.
The company's shares are up 5.4% from a week ago.
Balance Sheet Analysis
While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. We have a graphic representation of Mouwasat Medical Services' balance sheet and an in-depth analysis of the company's financial position.
If you're looking to trade Mouwasat Medical Services, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.
With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.
Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.
Sponsored ContentNew: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SASE:4002
Mouwasat Medical Services
Engages in the acquisition, management, operation, and maintenance of hospitals, medical centers, drug stores, and pharmacies in the Kingdom of Saudi Arabia.
Flawless balance sheet established dividend payer.
Market Insights
Community Narratives
